Effect of terbutaline on bronchoconstriction induced by nebulised pentamidine
- PMID: 2014493
- PMCID: PMC462972
- DOI: 10.1136/thx.46.2.122
Effect of terbutaline on bronchoconstriction induced by nebulised pentamidine
Abstract
The severity, duration, and reversibility of pentamidine induced bronchial narrowing was studied with and without pretreatment with nebulised terbutaline 10 mg in an open study of 40 patients seropositive for the human immunodeficiency virus (HIV). All subjects received pentamidine 300 mg in 5 ml water via an Acorn System 22 jet nebuliser. The forced expiratory volume in one second (FEV1) fell in all 20 patients given pentamidine alone, the mean maximum fall being 20.6%. In the 20 patients given pentamidine preceded by nebulised terbutaline the mean maximum fall in FEV1 was 4%; three subjects had a fall in FEV1 of more than 10%.
Similar articles
-
A comparison of several agents with two delivery systems for the prevention of airway narrowing induced by nebulised pentamidine isethionate.Respir Med. 1991 Nov;85(6):527-31. doi: 10.1016/s0954-6111(06)80272-6. Respir Med. 1991. PMID: 1663642
-
Aerosol pentamidine-induced bronchoconstriction. Predictive factors and preventive therapy.Chest. 1991 Sep;100(3):624-7. doi: 10.1378/chest.100.3.624. Chest. 1991. PMID: 1832372 Clinical Trial.
-
Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.Thorax. 1989 Jul;44(7):565-9. doi: 10.1136/thx.44.7.565. Thorax. 1989. PMID: 2788936 Free PMC article.
-
Pentamidine.Br J Clin Pract. 1989 May;43(5):153-7. Br J Clin Pract. 1989. PMID: 2686746 Review. No abstract available.
-
Prophylaxis of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus type 1.Semin Respir Infect. 1989 Dec;4(4):311-7. Semin Respir Infect. 1989. PMID: 2697054 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources